Building Testing Capacity for Epidemic-Prone Diseases

  • Version
  • Download 2154
  • File Size 1.65 MB
  • File Count 1
  • Create Date 24 May 2023
  • Last Updated 30 May 2023

Building Testing Capacity for Epidemic-Prone Diseases

Executive Summary

The provision of health and other services in the African region is challenging due to protracted humanitarian emergencies, poverty, lack of political commitment, and fragile health systems. This has resulted in a number of retrograde health indicators, an increase in the burden of infectious diseases, and the emergence and re-emergence of high-risk pathogens. Over the last few decades, many outbreaks and epidemics have been reported across the region with the potential for local health and socioeconomic impact as well as international spread, including Yellow fever, Rift Valley fever, Mpox, measles, crimean-congo Haemorrhagic fever, Dengue fever, Chikungunya fever, Ebola virus diseases, Marburg virus disease, Cholera, and COVID-19. Most of these outbreaks were not detected early due to the lack of real-time surveillance, lack of optimal functional laboratory networks, inadequate diagnostic testing capacity at both national and peripheral levels of healthcare, inadequate human and other resources, and lack of adequate technical and managerial capacities. Through its Africa Task Force for Novel Coronavirus (AFTCOR) Laboratory Technical Working Group, the Africa Centres for Disease Control and Prevention (Africa CDC) has developed guidance on “Building Testing Capacity for Epidemic-Prone Diseases”. The aim of this guidance is to enhance the surveillance and diagnostic capacity of African Union (AU) member states. The guidance provides the recommended testing approaches for surveillance and clinical diagnosis of epidemic-prone diseases, and details on the diagnostic technologies and laboratory capacity needed to conduct testing. Recommendations are provided on leveraging existing laboratory capacity to establish readiness to prevent, detect and respond to emerging and epidemic-prone infectious diseases, based on evidence and best practices for disease control.

Attached Files

FileAction
Building Testing Capacity for Epidemic-Prone DiseasesDownload

In Africa, the number of COVID-19 cases and affected countries has been increasing steadily. As of 24 April 2020, over 27,000 cases and 1,300 deaths have been reported in 52 countries. Community transmission is now widespread. The epidemic has the potential to result in substantial death and suffering in Africa due to four major factors:

  1. Increased risk of transmission,
  2. Increased risk of infection leading to severe illness,
  3. Increased risk of death from severe illness,
  4. Increased suffering among those who survive the pandemic.

This guidance document addresses how physical distancing (referred to in previous guidance documents as ‘social distancing’) can help slow down transmission.

Download Files
FileAction
Download in Portuguese Download
Download in FrenchDownload
Download in ArabicDownload
Download in EnglishDownload